| Name | Title | Contact Details |
|---|
Elementary is a company specializing in advanced machine vision inspection, utilizing AI and automation to enhance manufacturing processes. Founded in mid-2017 by experienced professionals from various sectors, the company aims to develop a new generation of manufacturing products that rely on computer vision and AI. Their platform automates traceability scans and integrates AI, machine vision, and automation into production lines. This approach focuses on improving quality, traceability, and root cause analyses, making manufacturing processes more efficient. Elementary emphasizes a human-in-the-loop strategy, enhancing collaboration between humans and machines to optimize working conditions and outcomes. Based in Los Angeles, California, Elementarys team includes roboticists, computer scientists, designers, and engineers. The company has attracted significant funding, including a $30 million Series B round led by Tiger Global, to support its innovative solutions in manufacturing. Their technology is utilized by notable clients across various industries, including Toyota in the automotive sector.
American Business Development Corporation (ABD) helps B2B service providers build scalable, high-impact business development (BD) operations. We specialize in structuring BD strategies, aligning marketing and outreach efforts, and securing key partnerships to drive growth. Whether through a customized Business Development Plan®, implementing BD processes, or serving as an outsourced BD team, ABD ensures companies have the tools, strategy, and execution needed to expand their client pipeline and increase revenue. ABD was founded on the belief that business development is built on relationships, not automation. We dont rely on spam emails or impersonal outreach. Instead, we focus on strategic engagement, tailored messaging, and real human connections to generate high-quality leads and long-term partnerships. Our expertise spans industries such as life sciences, medical devices, professional services, and international trade, helping companies break into new markets and optimize BD functions. For companies expanding into the U.S. market, ABD provides outsourced BD solutions, acting as a dedicated U.S.-based BD team. We represent companies at key industry conferences, execute outreach on partnering platforms, conduct meetings, and manage post-conference follow-up—ensuring that warm, engaged leads are seamlessly transferred to the clients internal team. This eliminates costly international travel while maximizing business development opportunities. ABD also supports export strategies, helping companies expand into foreign markets through strategic partnerships, trade mission planning, and regulatory alignment. With over 20 years of international economic development experience, we connect businesses with high-value clients and funding opportunities through government agencies, accelerators, and industry leaders. At ABD, we dont just generate leads—we build long-term, sustainable BD operations that drive growth beyond our engagement.
Every purpose-driven brand has a story worth sharing. Storykind ensures your message reaches the right audience, at the right time, and in the right way. We turn inertia into action and audiences into advocates—growing your brand for a better, kinder world. Contact us at hello@storykind.com.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Our roots belong with the Custom Cabinetmaker. We were cabinetmakers for years and identify with the values and qualities of the custom cabinetmaker. When it comes to developing relationships with our customers, our mission is Success for those we work with, as we build those relationships on our core values of Create Win-Wins, Do the Right Thing, and Make it Better. Were fanatical about assembling a great team, who continue to "make it better" with great products and innovative services for the Custom Cabinetmaker, and have been since 1989.